Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merz lifts aesthetics unit with $600m Ulthera takeover

This article was originally published in Clinica

Executive Summary

German pharmaceutical firm Merz is expanding its aesthetics business with the agreed acquisition of Ulthera, a company specializing in non-surgical skin lifting, for up to $600m. The deal would mark Merz’s largest purchase in its history. It also illustrates an increasing interest from pharma companies in aesthetics, following Valeant’s hostile $54bn bid for Botox developer Allergan – the latter has so far resisted its rival’s overtures.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts